Review



anti e2f1 polyclonal antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech anti e2f1 polyclonal antibody
    Anti E2f1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 198 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti e2f1 polyclonal antibody/product/Proteintech
    Average 96 stars, based on 198 article reviews
    anti e2f1 polyclonal antibody - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    96
    Proteintech anti e2f1 polyclonal antibody
    Anti E2f1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti e2f1 polyclonal antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti e2f1 polyclonal antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    ABclonal Biotechnology anti-e2f1-99aa polyclonal antibody
    Anti E2f1 99aa Polyclonal Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-e2f1-99aa polyclonal antibody/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-e2f1-99aa polyclonal antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    GeneTex rabbit polyclonal anti-e2f1
    Rabbit Polyclonal Anti E2f1, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-e2f1/product/GeneTex
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-e2f1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti e2f1 rabbit polyclonal antibody
    Anti E2f1 Rabbit Polyclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti e2f1 rabbit polyclonal antibody/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    anti e2f1 rabbit polyclonal antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    93
    OriGene anti e2f1
    ARRB1 controls cell proliferation and apoptosis in granule cell progenitors (GCPs) via <t>E2F1</t> acetylation. (A) Murine cerebellum Western blot. Representative images of endogenous GLI1 and ARRB1 in murine cerebella at different days (2, 5, 7, 15) of cerebellar development. GAPDH: loading control. (B–G) GCPs experiments. Shh was added to cultures of murine cerebellar GCPs that had or had not undergone siRNA-mediated silencing of ARRB1 (siArrb1). After 48 h of Shh stimulation, GCPs were assayed for: (B) Gli1 mRNA and protein levels (as a read-out of Shh signaling activity), and ARRB1 protein level; ACTIN as loading control; (C) proliferation reflected by bromodeoxyuridine (BrdU) uptake; (D) left: p27 mRNA levels ( (D) right and : Overexpression data are consistent); (E) differentiation reflected by β III tubulin mRNA levels; (F) apoptosis evaluated by TUNEL assay, and (G) ARRB1, E2F1, E2F1-ac, cleaved CASPASE-3 protein expression levels. ACTIN and HISTONE H3: loading controls. For Western blot, densitometry values are shown below the blots and densitometric graphs are presented in . Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Anti E2f1, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti e2f1/product/OriGene
    Average 93 stars, based on 1 article reviews
    anti e2f1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit polyclonal anti e2f1

    Rabbit Polyclonal Anti E2f1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti e2f1/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal anti e2f1 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    Proteintech anti e2f1
    Bioinformatic analysis predicted a <t>TFDP1/E2F1</t> complex that binds to the promoter of U2AF2 A . a heatmap showing the correlation between the expression of U2AF2 and the candidates TFs identified from CistroDB. B . A list of high potential candidate TFs modulating U2AF2 expression (Pearson’s r > 0.4). C . The high potential (relative score >0.85) binding site of TFDP1 (top panel) and E2F1 (bottom panel) in the promoter region of U2AF2 . Promoter scanning was conducted using the Jaspar database. D . IF staining of TFDP1 (green) and E2F1 (red) in SK-LMS-1 and SK-UT-1 cells. E-F . Co-IP assays to assess the interaction between endogenous TFDP1 and E2F1 in SK-LMS-1 (e) and SK-UT-1 (f) cells. IP was performed using mouse anti-E2F1 or rabbit anti-TFDP1. IgG served as a negative control. Scale bar: 20 μm.
    Anti E2f1, supplied by Proteintech, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti e2f1/product/Proteintech
    Average 99 stars, based on 1 article reviews
    anti e2f1 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit polyclonal e2f1
    Fig. 7. <t>E2F1</t> is stabilized in response to MPO. (A) HCT116 p53WT and (B) p53−/−cells were treated with MPO (20 μM) for 24–96 h and lysates from the nuclear and cytosolic fractions were subjected to Western blotting analysis using anti-E2F1 and anti-β actin antibodies. (C) HCT p53WT cells were treated with MPO (20 μM) for 24 h in the presence or absence of cycloheximide (CHX) (2.5–5 μg/ml) or actinomycin D (Act. D) (0.5 μg/ml) and cell lysates were subjected to Western blotting analysis and probed with anti-E2F1 or anti-β actin antibodies.
    Rabbit Polyclonal E2f1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal e2f1/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal e2f1 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    ARRB1 controls cell proliferation and apoptosis in granule cell progenitors (GCPs) via E2F1 acetylation. (A) Murine cerebellum Western blot. Representative images of endogenous GLI1 and ARRB1 in murine cerebella at different days (2, 5, 7, 15) of cerebellar development. GAPDH: loading control. (B–G) GCPs experiments. Shh was added to cultures of murine cerebellar GCPs that had or had not undergone siRNA-mediated silencing of ARRB1 (siArrb1). After 48 h of Shh stimulation, GCPs were assayed for: (B) Gli1 mRNA and protein levels (as a read-out of Shh signaling activity), and ARRB1 protein level; ACTIN as loading control; (C) proliferation reflected by bromodeoxyuridine (BrdU) uptake; (D) left: p27 mRNA levels ( (D) right and : Overexpression data are consistent); (E) differentiation reflected by β III tubulin mRNA levels; (F) apoptosis evaluated by TUNEL assay, and (G) ARRB1, E2F1, E2F1-ac, cleaved CASPASE-3 protein expression levels. ACTIN and HISTONE H3: loading controls. For Western blot, densitometry values are shown below the blots and densitometric graphs are presented in . Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum

    doi: 10.3389/fcell.2023.990711

    Figure Lengend Snippet: ARRB1 controls cell proliferation and apoptosis in granule cell progenitors (GCPs) via E2F1 acetylation. (A) Murine cerebellum Western blot. Representative images of endogenous GLI1 and ARRB1 in murine cerebella at different days (2, 5, 7, 15) of cerebellar development. GAPDH: loading control. (B–G) GCPs experiments. Shh was added to cultures of murine cerebellar GCPs that had or had not undergone siRNA-mediated silencing of ARRB1 (siArrb1). After 48 h of Shh stimulation, GCPs were assayed for: (B) Gli1 mRNA and protein levels (as a read-out of Shh signaling activity), and ARRB1 protein level; ACTIN as loading control; (C) proliferation reflected by bromodeoxyuridine (BrdU) uptake; (D) left: p27 mRNA levels ( (D) right and : Overexpression data are consistent); (E) differentiation reflected by β III tubulin mRNA levels; (F) apoptosis evaluated by TUNEL assay, and (G) ARRB1, E2F1, E2F1-ac, cleaved CASPASE-3 protein expression levels. ACTIN and HISTONE H3: loading controls. For Western blot, densitometry values are shown below the blots and densitometric graphs are presented in . Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: The following antibodies were used: anti-GLI1 (L42B10, Cell Signaling), anti-CASPASE-3 (D3R6Y, Cell Signaling), anti-β-ARRESTIN1 K-16 (sc-8182; Santa Cruz Biotechnology), anti-ACTIN I-19 (sc-1616; Santa Cruz Biotechnology), anti-E2F1 C-20 (sc-193; Santa Cruz Biotechnology), anti-E2F1 (acetyl K120/K125) (AP10555SU-N, Acris Antibodies); anti-ZIC1 (ab72694; Abcam); anti-PARP p85 Fragment (G7342; Promega), anti-SP1 1C6 (sc-420X; Santa Cruz Biotechnology), anti-PCNA (2586; Cell signaling), anti-H3 (ab 1971, Abcam), and anti-GAPDH (ab8245; Abcam).

    Techniques: Western Blot, Control, Activity Assay, Over Expression, TUNEL Assay, Expressing

    E2F1-ac targets’ transcripts after ARRB1 modulation. (A,B) Expression of pro-apoptotic E2F1-ac target genes ( Trp73, Casp3 and Casp7 ) in GCPs that had or had not undergone siArrb1 (black) or over-expression of Arrb1 (Arrb1-HA) (orange). (C,D) Expression of proliferative (grey) and epithelial mesenchymal transition (violet) E2f1-ac target genes ( Cdc25a, Birc5, Tyms, Zeb1, Zeb2, Vim and Fn1 ) in GCPs that had or had not undergone siArrb1. Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001. (E) IHC staining for ARRB1 and P27 in representative mouse cerebellum sections at several differentiation stages (p2, p4, p7, p10, p15) (upper panels). Magnification ×10; insets ×40. Scale bar, 250 µm. CASPASE-3 and CDC25A indexes (expressed as percentage) calculated as DAB positive cells of total number of cells (bottom panels). Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.001 vs. p10. # p < 0.05; ## p < 0.01 vs. p15.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum

    doi: 10.3389/fcell.2023.990711

    Figure Lengend Snippet: E2F1-ac targets’ transcripts after ARRB1 modulation. (A,B) Expression of pro-apoptotic E2F1-ac target genes ( Trp73, Casp3 and Casp7 ) in GCPs that had or had not undergone siArrb1 (black) or over-expression of Arrb1 (Arrb1-HA) (orange). (C,D) Expression of proliferative (grey) and epithelial mesenchymal transition (violet) E2f1-ac target genes ( Cdc25a, Birc5, Tyms, Zeb1, Zeb2, Vim and Fn1 ) in GCPs that had or had not undergone siArrb1. Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001. (E) IHC staining for ARRB1 and P27 in representative mouse cerebellum sections at several differentiation stages (p2, p4, p7, p10, p15) (upper panels). Magnification ×10; insets ×40. Scale bar, 250 µm. CASPASE-3 and CDC25A indexes (expressed as percentage) calculated as DAB positive cells of total number of cells (bottom panels). Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.001 vs. p10. # p < 0.05; ## p < 0.01 vs. p15.

    Article Snippet: The following antibodies were used: anti-GLI1 (L42B10, Cell Signaling), anti-CASPASE-3 (D3R6Y, Cell Signaling), anti-β-ARRESTIN1 K-16 (sc-8182; Santa Cruz Biotechnology), anti-ACTIN I-19 (sc-1616; Santa Cruz Biotechnology), anti-E2F1 C-20 (sc-193; Santa Cruz Biotechnology), anti-E2F1 (acetyl K120/K125) (AP10555SU-N, Acris Antibodies); anti-ZIC1 (ab72694; Abcam); anti-PARP p85 Fragment (G7342; Promega), anti-SP1 1C6 (sc-420X; Santa Cruz Biotechnology), anti-PCNA (2586; Cell signaling), anti-H3 (ab 1971, Abcam), and anti-GAPDH (ab8245; Abcam).

    Techniques: Expressing, Over Expression, Immunohistochemistry

    ARRB1-E2F1 complex direct regulates the expression of E2F1-ac pro-apoptotic targets. (A,B) qPCR-ChIP assay of ARRB1 in GCPs stimulated or not with Shh. Immunoprecipitation with IgG was performed as control. Eluted DNA was amplified by qPCR using primers specific for the regulatory region of the indicated genes. Actin and Gapdh (not shown) were used as endogenous non-enriched regions. qPCR data are presented as percentage of ChIP input controls. Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum

    doi: 10.3389/fcell.2023.990711

    Figure Lengend Snippet: ARRB1-E2F1 complex direct regulates the expression of E2F1-ac pro-apoptotic targets. (A,B) qPCR-ChIP assay of ARRB1 in GCPs stimulated or not with Shh. Immunoprecipitation with IgG was performed as control. Eluted DNA was amplified by qPCR using primers specific for the regulatory region of the indicated genes. Actin and Gapdh (not shown) were used as endogenous non-enriched regions. qPCR data are presented as percentage of ChIP input controls. Data represent means ± S.D., from at least three independent experiments; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: The following antibodies were used: anti-GLI1 (L42B10, Cell Signaling), anti-CASPASE-3 (D3R6Y, Cell Signaling), anti-β-ARRESTIN1 K-16 (sc-8182; Santa Cruz Biotechnology), anti-ACTIN I-19 (sc-1616; Santa Cruz Biotechnology), anti-E2F1 C-20 (sc-193; Santa Cruz Biotechnology), anti-E2F1 (acetyl K120/K125) (AP10555SU-N, Acris Antibodies); anti-ZIC1 (ab72694; Abcam); anti-PARP p85 Fragment (G7342; Promega), anti-SP1 1C6 (sc-420X; Santa Cruz Biotechnology), anti-PCNA (2586; Cell signaling), anti-H3 (ab 1971, Abcam), and anti-GAPDH (ab8245; Abcam).

    Techniques: Expressing, Immunoprecipitation, Control, Amplification

    ARRB1 controls NSCs apoptosis via E2F1 acetylation. (A) Effects of Arrb1-HA overexpression and mock transfection (control) of NSCs on ARRB1 and E2F1-ac protein levels (Western blot assay-left) and Trp73 and Cdc25a mRNA levels (right). * p < 0.05 vs. mock transfected cells (Mock). GAPDH: loading control for Western blot. (B) Western Blot analysis of endogenous ARRB1, E2F1, and E2F1-ac expression in NSCs cultured in SCM (0 h) and after 8–24 h culture in DFM. GAPDH: loading control. Effects of si-Arrb1 or scrambled control (siCtr) on (C) Trp73 and Cdc25a mRNA levels (left) and ARRB1 protein levels (Western blot assay-right) in NSCs cultured in SCM (0 h) and after 18 h culture in DFM. ACTIN: loading control for Western blot. For Western blot, densitometry values are shown below the blots and densitometric graphs are presented in . * p < 0.05 vs. scrambled control (siCtr).

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum

    doi: 10.3389/fcell.2023.990711

    Figure Lengend Snippet: ARRB1 controls NSCs apoptosis via E2F1 acetylation. (A) Effects of Arrb1-HA overexpression and mock transfection (control) of NSCs on ARRB1 and E2F1-ac protein levels (Western blot assay-left) and Trp73 and Cdc25a mRNA levels (right). * p < 0.05 vs. mock transfected cells (Mock). GAPDH: loading control for Western blot. (B) Western Blot analysis of endogenous ARRB1, E2F1, and E2F1-ac expression in NSCs cultured in SCM (0 h) and after 8–24 h culture in DFM. GAPDH: loading control. Effects of si-Arrb1 or scrambled control (siCtr) on (C) Trp73 and Cdc25a mRNA levels (left) and ARRB1 protein levels (Western blot assay-right) in NSCs cultured in SCM (0 h) and after 18 h culture in DFM. ACTIN: loading control for Western blot. For Western blot, densitometry values are shown below the blots and densitometric graphs are presented in . * p < 0.05 vs. scrambled control (siCtr).

    Article Snippet: The following antibodies were used: anti-GLI1 (L42B10, Cell Signaling), anti-CASPASE-3 (D3R6Y, Cell Signaling), anti-β-ARRESTIN1 K-16 (sc-8182; Santa Cruz Biotechnology), anti-ACTIN I-19 (sc-1616; Santa Cruz Biotechnology), anti-E2F1 C-20 (sc-193; Santa Cruz Biotechnology), anti-E2F1 (acetyl K120/K125) (AP10555SU-N, Acris Antibodies); anti-ZIC1 (ab72694; Abcam); anti-PARP p85 Fragment (G7342; Promega), anti-SP1 1C6 (sc-420X; Santa Cruz Biotechnology), anti-PCNA (2586; Cell signaling), anti-H3 (ab 1971, Abcam), and anti-GAPDH (ab8245; Abcam).

    Techniques: Over Expression, Transfection, Control, Western Blot, Expressing, Cell Culture

    Schematic model of ARRB1/E2F1-ac functions in GCPs and NSCs. Overview of roles played by ARRB1/E2F1-ac in normal cerebellar development. (A) : Committed neuronal precursors (i.e., NSCs grown in DFM, GCPs). In our previous works, we identified miR-326 as a miRNA necessary for maturation of granule cell progenitors (GCPs) into mature granule cells . Moreover, this miRNA is integrated into the first intron of the Arrb1 gene and shares the same regulatory regions as its host gene. miR-326 also contributes to ARRB1 functions by blunting proliferative signals mediated by E2F1, Hedgehog, and Notch, and by promoting cell differentiation ( ; ; ; ). Committed neuronal precursors express ARRB1 and mir-326, which regulate their development at multiple levels. Shh signaling upregulates ARRB1 levels and promotes its translocation to the nucleus. There ARRB1, in complex with P300, induces acetylation of E2F1 (E2F1-ac), redirecting the transcription factors activity from survival/proliferative gene targets towards those that promote apoptosis ( Trp73, Caspases 3 and 7 ). Interacting with CREB and P300, ARRB1 upregulates the expression and nuclear accumulation of P27, which eventually blocks cell cycle progression. miR-326 favors neuronal cell differentiations by inhibiting multiple survival/proliferative signaling: E2F1, Hedgehog (Hh) and Notch via direct binding of the 3′-UTRs of E2f1, Smo, Gli2, Notch1 and Notch2 . (B) : In NSCs, non-expression of ARRB1 and miR-326 promotes cell proliferation, survival, and stemness by favoring non-acetylated E2F1 activity and active Hedgehog (Hh) and Notch signaling.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum

    doi: 10.3389/fcell.2023.990711

    Figure Lengend Snippet: Schematic model of ARRB1/E2F1-ac functions in GCPs and NSCs. Overview of roles played by ARRB1/E2F1-ac in normal cerebellar development. (A) : Committed neuronal precursors (i.e., NSCs grown in DFM, GCPs). In our previous works, we identified miR-326 as a miRNA necessary for maturation of granule cell progenitors (GCPs) into mature granule cells . Moreover, this miRNA is integrated into the first intron of the Arrb1 gene and shares the same regulatory regions as its host gene. miR-326 also contributes to ARRB1 functions by blunting proliferative signals mediated by E2F1, Hedgehog, and Notch, and by promoting cell differentiation ( ; ; ; ). Committed neuronal precursors express ARRB1 and mir-326, which regulate their development at multiple levels. Shh signaling upregulates ARRB1 levels and promotes its translocation to the nucleus. There ARRB1, in complex with P300, induces acetylation of E2F1 (E2F1-ac), redirecting the transcription factors activity from survival/proliferative gene targets towards those that promote apoptosis ( Trp73, Caspases 3 and 7 ). Interacting with CREB and P300, ARRB1 upregulates the expression and nuclear accumulation of P27, which eventually blocks cell cycle progression. miR-326 favors neuronal cell differentiations by inhibiting multiple survival/proliferative signaling: E2F1, Hedgehog (Hh) and Notch via direct binding of the 3′-UTRs of E2f1, Smo, Gli2, Notch1 and Notch2 . (B) : In NSCs, non-expression of ARRB1 and miR-326 promotes cell proliferation, survival, and stemness by favoring non-acetylated E2F1 activity and active Hedgehog (Hh) and Notch signaling.

    Article Snippet: The following antibodies were used: anti-GLI1 (L42B10, Cell Signaling), anti-CASPASE-3 (D3R6Y, Cell Signaling), anti-β-ARRESTIN1 K-16 (sc-8182; Santa Cruz Biotechnology), anti-ACTIN I-19 (sc-1616; Santa Cruz Biotechnology), anti-E2F1 C-20 (sc-193; Santa Cruz Biotechnology), anti-E2F1 (acetyl K120/K125) (AP10555SU-N, Acris Antibodies); anti-ZIC1 (ab72694; Abcam); anti-PARP p85 Fragment (G7342; Promega), anti-SP1 1C6 (sc-420X; Santa Cruz Biotechnology), anti-PCNA (2586; Cell signaling), anti-H3 (ab 1971, Abcam), and anti-GAPDH (ab8245; Abcam).

    Techniques: Cell Differentiation, Translocation Assay, Activity Assay, Expressing, Binding Assay

    Journal: STAR Protocols

    Article Title: Optimized lentiviral vector transduction of adherent cells and analysis in sulforhodamine B proliferation and chromatin immunoprecipitation assays

    doi: 10.1016/j.xpro.2023.102109

    Figure Lengend Snippet:

    Article Snippet: Rabbit polyclonal anti-E2F1 , Cell Signaling Technology , CAT#3742S.

    Techniques: Western Blot, Virus, Bacteria, Recombinant, Protease Inhibitor, Magnetic Beads, Plasmid Preparation, Control, Software, Blocking Assay, Inverted Microscopy, Transferring, Spectrophotometry, Hood

    Bioinformatic analysis predicted a TFDP1/E2F1 complex that binds to the promoter of U2AF2 A . a heatmap showing the correlation between the expression of U2AF2 and the candidates TFs identified from CistroDB. B . A list of high potential candidate TFs modulating U2AF2 expression (Pearson’s r > 0.4). C . The high potential (relative score >0.85) binding site of TFDP1 (top panel) and E2F1 (bottom panel) in the promoter region of U2AF2 . Promoter scanning was conducted using the Jaspar database. D . IF staining of TFDP1 (green) and E2F1 (red) in SK-LMS-1 and SK-UT-1 cells. E-F . Co-IP assays to assess the interaction between endogenous TFDP1 and E2F1 in SK-LMS-1 (e) and SK-UT-1 (f) cells. IP was performed using mouse anti-E2F1 or rabbit anti-TFDP1. IgG served as a negative control. Scale bar: 20 μm.

    Journal: Bioengineered

    Article Title: U2 small nuclear RNA auxiliary factor 2, transcriptionally activated by the transcription factor Dp-1/E2F transcription factor 1 complex, enhances the growth and aerobic glycolysis of leiomyosarcoma cells

    doi: 10.1080/21655979.2022.2061286

    Figure Lengend Snippet: Bioinformatic analysis predicted a TFDP1/E2F1 complex that binds to the promoter of U2AF2 A . a heatmap showing the correlation between the expression of U2AF2 and the candidates TFs identified from CistroDB. B . A list of high potential candidate TFs modulating U2AF2 expression (Pearson’s r > 0.4). C . The high potential (relative score >0.85) binding site of TFDP1 (top panel) and E2F1 (bottom panel) in the promoter region of U2AF2 . Promoter scanning was conducted using the Jaspar database. D . IF staining of TFDP1 (green) and E2F1 (red) in SK-LMS-1 and SK-UT-1 cells. E-F . Co-IP assays to assess the interaction between endogenous TFDP1 and E2F1 in SK-LMS-1 (e) and SK-UT-1 (f) cells. IP was performed using mouse anti-E2F1 or rabbit anti-TFDP1. IgG served as a negative control. Scale bar: 20 μm.

    Article Snippet: The primary antibodies used include: anti-U2AF2 (1:1000, 15,624-1-AP, Proteintech), anti-GLUT1 (1: 2000, 66,290-1-Ig, Proteintech), anti-HK2 (1: 5000, 22,029-1-AP, Proteintech), anti-PGK1 (1: 1000, 17,811-1-AP, Proteintech), anti-PGAM1 (1: 2000, 16,126-1-AP, Proteintech), anti-TFDP1 (1:1000, sc-70,989, Santa Cruz Biotechnology, Dallas, TX, USA), anti-E2F1 (1:1000, M00257, Boster, Beijing, China). and anti-β-actin (1: 2000, 20,536-1-AP, Proteintech).

    Techniques: Expressing, Binding Assay, Staining, Co-Immunoprecipitation Assay, Negative Control

    The TFDP1/E2F1 complex enhances U2AF2 transcription A . A schematic image showing the predicted binding site of TFDP1 and E2F1 in the promoter region of U2AF2 . The positions of primers used for ChIP-qPCR assay were indicated by arrows. B . QRT-PCR was conducted to detect the expression of E2F1 and TFDP1 at the mRNA level in SK-LMS-1 cells 48 h after lentiviral mediated E2F1 or TFDP1 knockdown (n = 3). C . U2AF2 expression at the mRNA level (top panel) and E2F1, TFDP1 , and U2AF2 expression at the protein level (bottom panel) in SK-LMS-1 cells 48 h after lentiviral mediated E2F1 or TFDP1 knockdown alone or in combination (n = 3). D. Relative luciferase activity of pGL3-U2AF2-promoter-WT in SK-LMS-1 cells with lentiviral mediated E2F1 or TFDP1 knockdown alone or in combination (n = 3). E-F. ChIP-qPCR assay was performed to quantify the relative enrichment of U2AF2 promoter fragments (by primer sets indicated in panel A) in the ChIP samples immunoprecipitated by anti-E2F1 or anti-TFDP1 in the lysates of SK-LMS-1 cells with E2F1 or TFDP1 knockdown alone (shE2#1 or shTF#1) or in combination (shE2#1 and shTF#1) (n = 3). G-H. K-M survival analysis was performed to explore the differences in PFS (g) and DSS (h) in leiomyosarcoma patients with high or low TFDP1 expression. * p < 0.05, ** p < 0.01, *** p < 0.001. ShE2: shE2F1, ShtTF: shTFDP1.

    Journal: Bioengineered

    Article Title: U2 small nuclear RNA auxiliary factor 2, transcriptionally activated by the transcription factor Dp-1/E2F transcription factor 1 complex, enhances the growth and aerobic glycolysis of leiomyosarcoma cells

    doi: 10.1080/21655979.2022.2061286

    Figure Lengend Snippet: The TFDP1/E2F1 complex enhances U2AF2 transcription A . A schematic image showing the predicted binding site of TFDP1 and E2F1 in the promoter region of U2AF2 . The positions of primers used for ChIP-qPCR assay were indicated by arrows. B . QRT-PCR was conducted to detect the expression of E2F1 and TFDP1 at the mRNA level in SK-LMS-1 cells 48 h after lentiviral mediated E2F1 or TFDP1 knockdown (n = 3). C . U2AF2 expression at the mRNA level (top panel) and E2F1, TFDP1 , and U2AF2 expression at the protein level (bottom panel) in SK-LMS-1 cells 48 h after lentiviral mediated E2F1 or TFDP1 knockdown alone or in combination (n = 3). D. Relative luciferase activity of pGL3-U2AF2-promoter-WT in SK-LMS-1 cells with lentiviral mediated E2F1 or TFDP1 knockdown alone or in combination (n = 3). E-F. ChIP-qPCR assay was performed to quantify the relative enrichment of U2AF2 promoter fragments (by primer sets indicated in panel A) in the ChIP samples immunoprecipitated by anti-E2F1 or anti-TFDP1 in the lysates of SK-LMS-1 cells with E2F1 or TFDP1 knockdown alone (shE2#1 or shTF#1) or in combination (shE2#1 and shTF#1) (n = 3). G-H. K-M survival analysis was performed to explore the differences in PFS (g) and DSS (h) in leiomyosarcoma patients with high or low TFDP1 expression. * p < 0.05, ** p < 0.01, *** p < 0.001. ShE2: shE2F1, ShtTF: shTFDP1.

    Article Snippet: The primary antibodies used include: anti-U2AF2 (1:1000, 15,624-1-AP, Proteintech), anti-GLUT1 (1: 2000, 66,290-1-Ig, Proteintech), anti-HK2 (1: 5000, 22,029-1-AP, Proteintech), anti-PGK1 (1: 1000, 17,811-1-AP, Proteintech), anti-PGAM1 (1: 2000, 16,126-1-AP, Proteintech), anti-TFDP1 (1:1000, sc-70,989, Santa Cruz Biotechnology, Dallas, TX, USA), anti-E2F1 (1:1000, M00257, Boster, Beijing, China). and anti-β-actin (1: 2000, 20,536-1-AP, Proteintech).

    Techniques: Binding Assay, Quantitative RT-PCR, Expressing, Luciferase, Activity Assay, Immunoprecipitation

    Fig. 7. E2F1 is stabilized in response to MPO. (A) HCT116 p53WT and (B) p53−/−cells were treated with MPO (20 μM) for 24–96 h and lysates from the nuclear and cytosolic fractions were subjected to Western blotting analysis using anti-E2F1 and anti-β actin antibodies. (C) HCT p53WT cells were treated with MPO (20 μM) for 24 h in the presence or absence of cycloheximide (CHX) (2.5–5 μg/ml) or actinomycin D (Act. D) (0.5 μg/ml) and cell lysates were subjected to Western blotting analysis and probed with anti-E2F1 or anti-β actin antibodies.

    Journal: Cancer letters

    Article Title: Identification of a novel catalytic inhibitor of topoisomerase II alpha that engages distinct mechanisms in p53 wt or p53 -/- cells to trigger G2/M arrest and senescence.

    doi: 10.1016/j.canlet.2021.11.025

    Figure Lengend Snippet: Fig. 7. E2F1 is stabilized in response to MPO. (A) HCT116 p53WT and (B) p53−/−cells were treated with MPO (20 μM) for 24–96 h and lysates from the nuclear and cytosolic fractions were subjected to Western blotting analysis using anti-E2F1 and anti-β actin antibodies. (C) HCT p53WT cells were treated with MPO (20 μM) for 24 h in the presence or absence of cycloheximide (CHX) (2.5–5 μg/ml) or actinomycin D (Act. D) (0.5 μg/ml) and cell lysates were subjected to Western blotting analysis and probed with anti-E2F1 or anti-β actin antibodies.

    Article Snippet: The following antibodies were used in the study: Mouse monoclonal β-actin (Sigma Aldrich Co., St. Louis, MO), mouse monoclonal p53, p21, topo IIα, (BD Pharmingen, San Diego, CA, USA), mouse monoclonal phospho-p53(ser15), phospho-ATM(ser1981) (Cell Signaling Technology Inc., Danvers, MA), mouse monoclonal ATM, Chk2, Chk1 (Santa Cruz Biotechnology Inc., Santa Cruz, CA), mouse monoclonal phosphohistone H2AX(ser139), clone JBW301 (Upstate Biotechnology Inc., Lake Placid, NY), rabbit monoclonal phospho-Chk2(thr68), phospho-Chk1 (ser345) (Cell Signaling Technology Inc., Danvers, MA), rabbit polyclonal E2F1 (Cell Signaling Technology Inc., Danvers, MA), rabbit polyclonal topo IIα (TopoGEN, Inc., Columbus, OH), rabbit polyclonal ATR (Calbiochem, San Diego, CA), goat anti-mouse IgG HRP conjugated and goat anti-rabbit IgG HRP conjugated secondary antibodies (Pierce Chemical Co., Rockford, IL).

    Techniques: Western Blot